Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;6(1):38.
doi: 10.1186/s12348-016-0102-3. Epub 2016 Oct 18.

A national survey of Canadian ophthalmologists to determine awareness of published guidelines for the management of uveitis

Affiliations

A national survey of Canadian ophthalmologists to determine awareness of published guidelines for the management of uveitis

Crystal S Y Cheung et al. J Ophthalmic Inflamm Infect. 2016 Dec.

Abstract

Background: The objectives of this study are to assess Canadian ophthalmologists' awareness of established uveitis treatment guidelines and clinical management of uveitis and to assess the frequency of government applications for immunomodulatory therapy (IMT) and identify primary prescribers. A 25-item questionnaire was sent to 759 practicing Canadian ophthalmologists. Six questions assessed demographics including the year of residency completion, training by uveitis specialists during residency, and fellowship training. Five questions assessed application of guidelines to clinical scenarios, and 12 questions assessed referral patterns and success of obtaining coverage for IMT.

Results: Of 144 respondents, 12 (8.3 %) were uveitis specialists; 45.1 % of respondents had uveitis training during residency by a uveitis specialist. Sixty-one percent reported awareness of management guidelines. Recent graduates (2001-2012) referred patients to uveitis specialists (55.3 %) less frequently than earlier graduates. Recent graduates also managed uveitis patients more frequently with corticosteroid injections (15.6 %) than those who graduated before 1980 (9.75 %). The majority (93.6 %) of respondents submitted less than six IMT funding applications for provincial drug coverage yearly, and 5.5 % reported prescribing IMT themselves, rather than referring to other specialists.

Conclusions: Although greater than half of respondents reported awareness of uveitis treatment guidelines, Canadian ophthalmologists' awareness of uveitis treatment guidelines and application of the guidelines to patient care could be improved. Few applications are made for IMT, and the majority of applications are sent by non-ophthalmologists. This suggests the need for further education of ophthalmologist about uveitis treatment guidelines and for more ophthalmologists trained to manage uveitis with IMT.

Keywords: Guidelines; Management; Uveitis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The year of residency completion in association with the (a) proportion of total correct responses to clinical scenario questions (p = 0.0208 for 2001–2012 vs 1981–2000; p = 0.0067 for 2001–2012 vs 1960–1980), (b) frequency of referral to uveitis specialists, and (c) frequency of managing patients with corticosteroid injections in clinical scenario questions

Similar articles

Cited by

References

    1. Durrani OM, Tehrani NN, Marr JE, et al. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159–1162. doi: 10.1136/bjo.2003.037226. - DOI - PMC - PubMed
    1. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516. doi: 10.1016/j.ajo.2005.03.057. - DOI - PMC - PubMed
    1. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14:303–308. doi: 10.1007/BF00163549. - DOI - PubMed
    1. Durrani K, Zakka FR, Ahmed M, et al. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammation disease. Surv Ophthalmol. 2011;56:474–510. doi: 10.1016/j.survophthal.2011.05.003. - DOI - PubMed
    1. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513. doi: 10.1016/S0002-9394(00)00659-0. - DOI - PubMed

LinkOut - more resources